MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "etc): Clinical features"

  • 2017 International Congress

    A retrospective analysis of clinical forms and age of onset of biallelic Huntington disease patients from an Argentinean Center

    M. Cesarini, V. Parisi, G. Persi, J. Etcheverry, A. Sanguinetti, F. Squitieri, E. Gatto (Buenos Aires, Argentina)

    Objective: To compare AO and clinical presentation in Argentinean bi-allelic (BHD) patients, ie one mutated allele and one either intermediate (IA, 27-35 CAG repeats) or…
  • 2017 International Congress

    Clinical and genetic characterization of Huntington’s disease in relation to the age and type of onset.

    L. Mendoza Vega, M. Rodríguez-Violante, A. Cervantes-Arriaga, A. De-la-Cruz-Landero, N. Davila-Avila, K. Salinas-Barboza, S. Isais-Millan (Mexico City, Mexico)

    Objective: To describe the clinical features and CAG repeats in a large population of Mexican patients with Huntington's disease and its relation to the age…
  • 2017 International Congress

    Down-regulation of miR-9* in the peripheral leukocytes of Huntington’s Disease patients

    K.-H. Chang, Y.-R. Wu, C.-M. Chen (Taoyuan County, Taiwan)

    Objective: To determine whether the alterations of microRNA expression in central nervous tissues can be detected in peripheral leukocytes in Huntington's disease (HD) patients. Background: Huntington’s…
  • 2017 International Congress

    Prescription pattern of treatment in Mexican patients with Huntington’s Disease.

    A. De-la-Cruz, L. Mendoza Vega, N. Davila Avila, K. Salinas Barboza, S. Isais Millan, A. Cervantes Arriaga, M. Rodriguez Violante (Ciudad de Mexico, Mexico)

    Objective: To describe the prescription pattern for the treatment of HD in a sample of Mexican patients from a tertiary referral center. Background: Huntington’s disease…
  • 2017 International Congress

    The neural correlates of apathy in premanifest and manifest Huntington’s disease: A cross-sectional multimodal imaging study

    S. Martinez-Horta, J. Perez-Perez, F. Sampedro, M. Carceller, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To delineate the brain correlates of apathy severity by means of glucose metabolism (18-FDG PET), grey-matter (GM) and white-matter (WM; FA-DTI) changes and relations…
  • 2017 International Congress

    Prevalence of substance abuse in Huntington´s disease patients and its relationship with neuropsychiatric symptoms

    K. SALINAS BARBOZA, L. MENDOZA VEGA, A. CRUZ LANDERO, S. ISAIS MILLAN, M. RODRIGUEZ VIOLANTE, A. CERVANTES ARRIAGA, N. DAVILA AVILA (MEXICO, Mexico)

    Objective: To describe the prevalence of substance abuse and its relationship with neuropsychiatric features in Huntington’s disease (HD). Background: Substance abuse is not well established…
  • 2017 International Congress

    Screening of cognitive impairment in Huntington’s disease with the Parkinson’s Disease – Cognitive Rating Scale (PD-CRS)

    S. Martinez-Horta, A. Horta-Barba, J. Perez-Perez, J. Pagonabarraga, J. Marin-Lahoz, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore the psychometric properties of the PD-CRS as compared to two commonly used measures (the MMSE and the UHDRS Cognitive score) for detecting…
  • 2017 International Congress

    Evidence-based Brazilian Physicaltherapy Guideline for Huntington´s Disease

    T. Capato, M. Haddad, E. Barbosa, M.E. Piemonte (Sao Paulo, Brazil)

    Objective: Identify the Evidence based Physicaltherapy available for HD and provide recommendations to physicians   Background: In Huntington’s Disease (HD) Chorea is usually presented in any phase…
  • 2017 International Congress

    Predictors for psychosis in Huntington’s disease: preliminary analysis of the Enroll-HD database.

    N. Rocha, E. Furr-Stimming, A. Teixeira (Houston, TX, USA)

    Objective: To evaluate predictors for psychosis in HD. Background: Behavioral problems are present across all stages of HD, even preceding the development of the motor…
  • 2017 International Congress

    Admission Diagnoses and Eventual Discharge Dispositions for Hospitalized Huntington’s Disease Patients: Results of a Nationwide Survey

    S. Gupta, F. Benesh, V. Sung (Birmingham, AL, USA)

    Objective: To better understand the causes of acute illness and its consequences for subsequent inpatient care in patients with Huntington’s Disease (HD). Background: HD is…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley